DIAMYD MEDICAL
Diamyd Medical develops the diabetes vaccine Diamyd®, an antigen-specific immunotherapy based on the exclusively licensed GAD-molecule. GABA constitutes alongside with the diabetes vaccine a key asset in Diamyd Medical and the Company uses its GABA in-licensed technology to develop a proprietary GABA drug product. Diamyd Medical’s shares are traded on Nasdaq Stockholm First North, ticker DMYD B.
DIAMYD MEDICAL
Industry:
Biotechnology
Founded:
1994-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.diamyd.com
Total Employee:
1+
Status:
Active
Contact:
+46 8 661 00 26
Email Addresses:
[email protected]
Total Funding:
100 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag Japanese Yen
Investors List
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Pre Seed Round - Diamyd Medical
Official Site Inspections
http://www.diamyd.com Semrush global rank: 6.9 M Semrush visits lastest month: 706
- Host name: shww-0114.s.beebyte.se
- IP address: 185.133.206.132
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
Loading ... 